Bortezomib

Overview

Bortezomib is a proteasome inhibitor used as an anticancer drug for the treatment of multiple myeloma and certain types of lymphoma. It works by interrupting the proteasome pathway, leading to cellular apoptosis in cancer cells.

API suppliers (22)

Suppliers of Bortezomib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• SHILPA PHARMA LIFESCIENCES LTDIndia2 active DMF
• APICORE US LLCUnited States1 active DMF
• TAPI NL BVNetherlands1 active DMF
• HUBEI HONCH PHARMACEUTICAL CO LTD1 active DMF
• BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• SCINOPHARM TAIWAN LTDTaiwan1 active DMF
• Reliance Life Sciences Pvt. Ltd.India1 active DMF GMP on record
• Gland Chemicals Private LimitedIndia1 active DMF
• Natco PharmaIndia1 active DMF GMP on record
• Laurus Labs LimitedIndia1 active DMF GMP on record
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• Jiangsu Hansoh Pharmaceutical Group Company LimitedChina1 active DMF GMP on record
• MSN Laboratories Private LimitedIndia1 active DMF GMP on record
• Granules India LimitedIndia1 active DMF GMP on record
• SHIVALIK RASAYAN LTDIndia1 active DMF
• HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChina1 active DMF
• ARTHUR GROUP LLCAustralia1 active DMF
• SEACROSS PHARMA USA INCChina1 active DMF
• Viwit Pharmaceutical Co., Ltd.China
• Cipla USA, Inc.USA
• Zhejiang Hisun Pharmaceutical Co., Ltd.China GMP on record

Therapeutic areas